XBIOTECH INC (XBIT) Stock Income Statement
NASDAQ:XBIT - Nasdaq - CA98400H1029 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 4.01M | 18.39M | |||
| Cost Of Goods | N/A | N/A | 0.00 | 650.00K | 5.82M | |||
| Gross Profit | N/A | N/A | 0.00 | 3.36M | 12.57M | |||
| Operating Expenses | 45.20M | 42.00M | 37.51M | 37.85M | 37.66M | |||
| Research and Development | 39.55M | N/A | 32.85M | 31.54M | 28.27M | |||
| Selling, General, and Administrative Expenses | 5.62M | 4.71M | 4.66M | 6.31M | 9.39M | |||
| Operating Income | -45.20M | -42.00M | -37.51M | -34.49M | -25.08M | |||
| Interest Income/Expense | 4.50M | N/A | 12.31M | 1.02M | -240.00K | |||
| Other Income/Expense | 1.23M | 3.00M | 883.00K | -120.00K | -130.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -39.41M | -39.00M | -24.31M | -33.59M | -25.46M | |||
| Income Tax | -33.00K | -30.00K | 244.00K | -690.00K | -8.04M | |||
| Net Income | -39.41M | -39.00M | -24.56M | -32.90M | -17.41M | |||
| EBITDA | -43.45M | -40.26M | -35.77M | -31.88M | -22.43M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.30 | -1.30 | -0.81 | -1.08 | -0.58 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | 83.79% | 68.35% | |||
| Profit Margin | N/A | N/A | N/A | -820.45% | -94.67% | |||
| Operating Profit Margin | N/A | N/A | N/A | -860.10% | -136.38% | |||
All data in USD